Non-invasive Prenatal Diagnostic Validation Study

CompletedOBSERVATIONAL
Enrollment

1,781

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Chromosome 13 AneuploidyChromosome 18 AneuploidyChromosome 21 AneuploidySex Chromosome AberrationsOther Microdeletions
Interventions
PROCEDURE

Blood draw

Blood is drawn at the appropriate time given their cohort inclusion.

PROCEDURE

Cheek swab/Saliva Sampling

In lieu of blood draw, male relatives may donate cheek swab or saliva sample. Children born to participating women can donate cheek swab or saliva sample soon after birth.

Trial Locations (1)

94063

Natera, Inc, Redwood City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT01574781 - Non-invasive Prenatal Diagnostic Validation Study | Biotech Hunter | Biotech Hunter